Serostim® (somatropin for injection) is a recombinant human growth hormone indicated for the treatment of HIV wasting in patients receiving antiretroviral therapy.

Serostim® reverses the underlying metabolic disturbance that occurs in HIV-associated wasting through its protein-building and protein-sparing activity, which promotes a significant increase in the patient’s lean body mass and weight. It helps the body build and maintain weight and lean body mass. It also allows the metabolism to function more normally, using fat for energy instead of lean body mass.

Serostim® is the product which has been the most extensively tested in HIV-associated wasting. It is also the first and only biotechnology-derived drug approved for HIV-associated wasting by the FDA in the USA.

Serostim®: For information on Serostim®, US residents should visit www.emdserono.com